DHURWASULU Baledi,GRETHER Uwe,NETTEKOVEN Matthias,ROEVER Stephan,ROGERS-EVANS Mark,SCHULZ-GASCH Tanja,SCHULZ-GASCH Ta
申请号：
SI201330591
公开号：
SI2928882T1
申请日:
2013.12.04
申请国别(地区):
SI
年份:
2017
代理人:
摘要：
The invention relates to a compound of formula (I) wherein R1 to R4 are defined as in the description and in the claims. The compound of formula (I) is a CB2 receptor agonist for use in the treatment of several disorders, such as pain, atherosclerosis and glaucoma.
